| Dr John T Swisher Iv, DO, CAQ, FAAFP | |
|
910 N Eisenhower Ave, Mason City, IA 50401-1552 | |
| (641) 428-5911 | |
| (641) 428-5985 |
| Full Name | Dr John T Swisher Iv |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 910 N Eisenhower Ave, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942311584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | 8418 (South Dakota) | Secondary |
| 207QS0010X | Family Medicine - Sports Medicine | 03815 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Home Care | Mason city, IA | Home health agency |
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Hancock County Health System | Britt, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.
In a sit-down interview with CNN, 2020 Democratic presidential primary candidate and former Vice President Joe Biden touted the Obama administration's passage of the Affordable Care Act, asserting that this law evened out the playing field when it came to insurance coverage of mental and physical health.
With disease burden shifting from infectious diseases to non-communicable diseases (NCDs) over the coming years, "African health scientists need more funding and support to overcome the barriers and deal with a changing health situation on the continent," Olive Shisana, chief executive officer of the South African Human Sciences Research Council, said during a keynote address at last week's World Health Summit in Berlin, Germany, SciDev.Net reports.
› Verified 4 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.
In a sit-down interview with CNN, 2020 Democratic presidential primary candidate and former Vice President Joe Biden touted the Obama administration's passage of the Affordable Care Act, asserting that this law evened out the playing field when it came to insurance coverage of mental and physical health.
With disease burden shifting from infectious diseases to non-communicable diseases (NCDs) over the coming years, "African health scientists need more funding and support to overcome the barriers and deal with a changing health situation on the continent," Olive Shisana, chief executive officer of the South African Human Sciences Research Council, said during a keynote address at last week's World Health Summit in Berlin, Germany, SciDev.Net reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John T Swisher Iv, DO, CAQ, FAAFP 621 S Illinois Ave, Mason City, IA 50401-5405 Ph: (641) 428-3041 | Dr John T Swisher Iv, DO, CAQ, FAAFP 910 N Eisenhower Ave, Mason City, IA 50401-1552 Ph: (641) 428-5911 |
News Archive
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.
In a sit-down interview with CNN, 2020 Democratic presidential primary candidate and former Vice President Joe Biden touted the Obama administration's passage of the Affordable Care Act, asserting that this law evened out the playing field when it came to insurance coverage of mental and physical health.
With disease burden shifting from infectious diseases to non-communicable diseases (NCDs) over the coming years, "African health scientists need more funding and support to overcome the barriers and deal with a changing health situation on the continent," Olive Shisana, chief executive officer of the South African Human Sciences Research Council, said during a keynote address at last week's World Health Summit in Berlin, Germany, SciDev.Net reports.
› Verified 4 days ago
David H Hanson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 S Taylor Ave, Mason City, IA 50401 Phone: 641-422-7766 Fax: 641-422-7788 | |
Dr. Mahad Rayale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 | |
Dr. Chad M Mccambridge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw, Suite 340, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7788 | |
Patrick Alan Courtney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw Ste 240, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7125 | |
Amanda Tran, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw Ste 340, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7788 | |
Wei Song, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 S Taylor Ave, Mason City, IA 50401 Phone: 641-422-7779 | |
Dr. Arla Mcvicker, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 520 S Pierce Ave, Suite 150, Mason City, IA 50401 Phone: 641-421-8077 Fax: 641-494-5005 |